Insider Transactions in Q1 2021 at Dolby Laboratories, Inc. (DLB)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 17
2021
|
Dagmar Dolby |
SELL
Bona fide gift
|
Indirect |
18,500
-100.0%
|
-
|
Mar 17
2021
|
Dagmar Dolby |
BUY
Conversion of derivative security
|
Indirect |
18,500
+50.0%
|
-
|
Mar 09
2021
|
Kevin J Yeaman President and CEO |
SELL
Open market or private sale
|
Indirect |
29,457
-26.66%
|
$2,916,243
$99.86 P/Share
|
Mar 09
2021
|
Kevin J Yeaman President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
29,457
+32.09%
|
$1,089,909
$37.35 P/Share
|
Mar 01
2021
|
Mark Andrew Sherman EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
13,000
-20.63%
|
$1,300,000
$100.0 P/Share
|
Mar 01
2021
|
Mark Andrew Sherman EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+17.1%
|
$585,000
$45.5 P/Share
|
Feb 24
2021
|
Emily Rollins |
BUY
Grant, award, or other acquisition
|
Direct |
2,462
+50.0%
|
-
|
Feb 23
2021
|
Todd Pendleton SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
10,229
-23.69%
|
$971,755
$95.09 P/Share
|
Feb 23
2021
|
Todd Pendleton SVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,229
+19.15%
|
$695,572
$68.4 P/Share
|
Feb 21
2021
|
Peter C Gotcher |
BUY
Grant, award, or other acquisition
|
Direct |
2,661
+6.1%
|
-
|
Feb 19
2021
|
Todd Pendleton SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
14,469
-9.07%
|
$1,360,086
$94.06 P/Share
|
Feb 19
2021
|
Todd Pendleton SVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,163
+8.78%
|
$790,595
$65.14 P/Share
|
Feb 16
2021
|
Mark Andrew Sherman EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
13,000
-20.63%
|
$1,235,000
$95.0 P/Share
|
Feb 16
2021
|
Mark Andrew Sherman EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+17.1%
|
$585,000
$45.5 P/Share
|
Feb 09
2021
|
Kevin J Yeaman President and CEO |
SELL
Open market or private sale
|
Indirect |
34,814
-28.75%
|
$3,168,074
$91.9 P/Share
|
Feb 09
2021
|
Kevin J Yeaman President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
29,457
+30.32%
|
$1,089,909
$37.35 P/Share
|
Feb 05
2021
|
Mark Andrew Sherman EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
27,663
-6.77%
|
$2,517,333
$91.91 P/Share
|
Feb 05
2021
|
Mark Andrew Sherman EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
26,000
+14.59%
|
$1,170,000
$45.5 P/Share
|
Feb 03
2021
|
Ryan Nicholson VP, CAO and Corp. Controller |
SELL
Open market or private sale
|
Direct |
2,237
-17.95%
|
$203,567
$91.01 P/Share
|
Feb 02
2021
|
Micheline Chau Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,661
+4.19%
|
-
|
Feb 02
2021
|
Lewis Chew EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-22.12%
|
$2,700,000
$90.82 P/Share
|
Feb 02
2021
|
Lewis Chew EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+18.12%
|
$1,260,000
$42.98 P/Share
|
Feb 02
2021
|
David Dolby |
BUY
Grant, award, or other acquisition
|
Direct |
2,661
+3.36%
|
-
|
Feb 02
2021
|
N William Jasper Jr Director |
SELL
Open market or private sale
|
Indirect |
3,627
-34.13%
|
$326,430
$90.33 P/Share
|
Feb 02
2021
|
Simon Segars |
BUY
Grant, award, or other acquisition
|
Direct |
2,661
+7.34%
|
-
|
Feb 02
2021
|
Roger S Siboni Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,661
+7.11%
|
-
|
Feb 02
2021
|
Anjali Sud |
BUY
Grant, award, or other acquisition
|
Direct |
2,661
+23.07%
|
-
|
Feb 02
2021
|
Avadis Tevanian |
SELL
Open market or private sale
|
Indirect |
1,814
-3.46%
|
$163,260
$90.0 P/Share
|
Feb 02
2021
|
Avadis Tevanian |
BUY
Grant, award, or other acquisition
|
Direct |
2,661
+50.0%
|
-
|